ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines (Q39367632)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines |
scientific article |
Statements
1 reference
ErbB3 expression predicts sensitivity to elisidepsin treatment: in vitro synergism with cisplatin, paclitaxel and gemcitabine in lung, breast and colon cancer cell lines (English)
1 reference
Cristina Teixidó
1 reference
Elisabet Arguelaguet
1 reference
Berta Pons
1 reference
Miguel Aracil
1 reference
Jose Jimeno
1 reference
Rosa Somoza
1 reference
Roso Marés
1 reference
Santiago Ramón Y Cajal
1 reference
Javier Hernández-Losa
1 reference
3 April 2012
1 reference
1 reference
Identifiers
1 reference